Posted in | News

UCB Group Sell Pharmaceutical Manufacturing Factory

Sep 3 2004

Related Stories

UCB announced today the sale of its factory in Limay to Nextpharma, who is a European leader in pharmaceutical manufacturing. This sale is part of the continuing process to optimize the efficiency of UCB manufacturing capacity.

The factory, which at present employs 105 people, specializes in the production of medicines mostly in the form of drinkable liquids (bottles and vials), creams, ointments and sprays.

No redundancies will result directly from this sale. In addition, UCB Pharma France, where almost 500 people are employed, is one of the Group’s most important pharmaceutical subsidiaries in Europe and it will go on growing.

For more information on pharmaceuticals, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback